Giovanni Targher
#91,175
Most Influential Person Now
Researcher
Giovanni Targher's AcademicInfluence.com Rankings
Giovanni Targherbiology Degrees
Biology
#4168
World Rank
#6258
Historical Rank
Biotechnology
#24
World Rank
#24
Historical Rank
Cell Biology
#100
World Rank
#105
Historical Rank
Molecular Biology
#304
World Rank
#309
Historical Rank
Download Badge
Biology
Giovanni Targher's Degrees
- PhD Biomedical Sciences University of Milan
- Masters Biotechnology University of Milan
- Bachelors Biology University of Milan
Similar Degrees You Can Earn
Why Is Giovanni Targher Influential?
(Suggest an Edit or Addition)Giovanni Targher's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. (2000) (2346)
- NAFLD: a multisystem disease. (2015) (1820)
- Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. (2010) (1381)
- Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis (2013) (1332)
- A new definition for metabolic associated fatty liver disease: an international expert consensus statement. (2020) (1099)
- Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. (2009) (864)
- Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. (1998) (851)
- Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis. (2016) (798)
- Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases (2017) (682)
- Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. (2005) (573)
- High Serum Uric Acid as a Novel Risk Factor for Type 2 Diabetes (2008) (562)
- HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. (2002) (559)
- Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. (2007) (531)
- Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta‐analysis (2016) (477)
- 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. (2009) (431)
- Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence? (2018) (428)
- Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon? (2008) (389)
- Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. (2007) (382)
- Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups. (2015) (358)
- Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis (2018) (356)
- COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies (2020) (318)
- The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study (2004) (311)
- Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. (2006) (300)
- Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients (2008) (300)
- Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 randomized trial) (2013) (294)
- Obesity Is a Risk Factor for Greater COVID-19 Severity (2020) (292)
- Serum 25‐hydroxyvitamin D3 concentrations and carotid artery intima‐media thickness among type 2 diabetic patients (2006) (256)
- Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus (2018) (248)
- Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. (2009) (248)
- AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions. (2017) (243)
- Non‐alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens (2007) (240)
- Clinical Review: Nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications. (2013) (239)
- Prevalence of subclinical hypothyroidism in patients with chronic kidney disease. (2008) (236)
- Arterial thrombus formation in cardiovascular disease (2011) (232)
- NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications (2020) (231)
- Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study. (1996) (229)
- Uric acid as a target of therapy in CKD. (2013) (227)
- Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease. (2014) (224)
- Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis. (2018) (223)
- The paradoxical relationship between serum uric acid and cardiovascular disease. (2008) (222)
- Serum Uric Acid Levels and Incident Chronic Kidney Disease in Patients With Type 2 Diabetes and Preserved Kidney Function (2011) (221)
- Complications, morbidity and mortality of nonalcoholic fatty liver disease. (2020) (219)
- Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus. (1997) (216)
- Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: role of visceral fat accumulation. (2004) (214)
- NASH Predicts Plasma Inflammatory Biomarkers Independently of Visceral Fat in Men (2008) (212)
- Moderate red wine consumption and cardiovascular disease risk: beyond the "French paradox". (2010) (203)
- Disorders of hemostasis associated with chronic kidney disease. (2010) (202)
- The complex link between NAFLD and type 2 diabetes mellitus — mechanisms and treatments (2021) (200)
- Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis. (2010) (198)
- Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes. (2010) (198)
- Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease (2017) (194)
- Prevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic Patients (2007) (192)
- Effects of moderate-intensity exercise training on plasma biomarkers of inflammation and endothelial dysfunction in older patients with type 2 diabetes. (2006) (192)
- Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications (2007) (191)
- Non-alcoholic fatty liver disease and risk of cardiovascular disease. (2016) (188)
- Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: A meta-analysis of observational studies (2020) (183)
- Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease. (2008) (182)
- Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease (2006) (179)
- Global epidemiology of nonalcoholic fatty liver disease: Meta‐analytic assessment of prevalence, incidence, and outcomes (2016) (177)
- Nonalcoholic Fatty Liver Disease Is Associated With Left Ventricular Diastolic Dysfunction in Patients With Type 2 Diabetes (2012) (169)
- NAFLD as a driver of chronic kidney disease. (2020) (169)
- Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: is there a link? (2011) (167)
- Relationship between red blood cell distribution width and kidney function tests in a large cohort of unselected outpatients (2008) (167)
- Non-Alcoholic Fatty Liver Disease Is Associated with an Increased Incidence of Atrial Fibrillation in Patients with Type 2 Diabetes (2013) (163)
- Cardiovascular events during World Cup soccer. (2008) (163)
- Increased prevalence of cardiovascular disease in Type 2 diabetic patients with non‐alcoholic fatty liver disease (2006) (163)
- Predictors of estimated GFR decline in patients with type 2 diabetes and preserved kidney function. (2012) (160)
- Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores (2020) (159)
- Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease (2018) (159)
- Non‐alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non‐diabetic men. Role of visceral adipose tissue (2005) (159)
- CKD and nonalcoholic fatty liver disease. (2014) (154)
- Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals (2020) (153)
- Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C. (2007) (153)
- Visceral fat accumulation and its relation to plasma hemostatic factors in healthy men. (1996) (151)
- Intimal-Medial Thickness of the Carotid Artery in Nondiabetic and NIDDM Patients: Relationship with insulin resistance (1997) (148)
- Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey. (2013) (146)
- Effects of glucosamine infusion on insulin secretion and insulin action in humans. (2000) (144)
- Elevated Serum Uric Acid Concentrations Independently Predict Cardiovascular Mortality in Type 2 Diabetic Patients (2009) (135)
- ABO blood group, hypercoagulability, and cardiovascular and cancer risk (2012) (133)
- Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients (2010) (133)
- Psoriasis and the metabolic syndrome. (2018) (130)
- Ectopic Fat, Insulin Resistance, and Nonalcoholic Fatty Liver Disease: Implications for Cardiovascular Disease (2014) (130)
- Increased risk of cardiovascular disease and chronic kidney disease in NAFLD (2012) (128)
- MAFLD and risk of CKD. (2020) (125)
- Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy (2005) (125)
- Patients with diabetes are at higher risk for severe illness from COVID-19 (2020) (124)
- The Role of Iron in Diabetes and Its Complications (2007) (123)
- Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes? (2016) (122)
- Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome. (2009) (118)
- In‐hospital and 1‐year mortality associated with diabetes in patients with acute heart failure: results from the ESC‐HFA Heart Failure Long‐Term Registry (2017) (118)
- Mortality From Chronic Liver Diseases in Diabetes (2014) (117)
- Nonalcoholic Fatty Liver Disease Is Independently Associated With an Increased Incidence of Chronic Kidney Disease in Patients With Type 1 Diabetes (2014) (116)
- Inherited platelet disorders. (2008) (116)
- Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach. (2021) (115)
- Decreased plasma adiponectin concentrations are closely associated with nonalcoholic hepatic steatosis in obese individuals (2004) (115)
- The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality (2021) (114)
- Extrapulmonary complications of COVID‐19: A multisystem disease? (2020) (114)
- Cardiovascular and systemic risk in nonalcoholic fatty liver disease - atherosclerosis as a major player in the natural course of NAFLD. (2013) (114)
- Iron and thrombosis (2007) (113)
- Clinical usefulness of measuring red blood cell distribution width on admission in patients with acute coronary syndromes (2009) (103)
- Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes. (2013) (102)
- Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled Type 2 diabetic patients (2006) (101)
- Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis. (2021) (100)
- Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials (2021) (99)
- Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease (2006) (96)
- Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV (2016) (96)
- Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases. (2017) (95)
- Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease. (2017) (95)
- Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis (2020) (90)
- Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease (2016) (90)
- Help me, Doctor! My D-dimer is raised (2008) (89)
- Increased mean platelet volume in patients with acute coronary syndromes. (2009) (89)
- Relationship between high-sensitivity C-reactive protein levels and liver histology in subjects with non-alcoholic fatty liver disease. (2006) (89)
- Liver Steatosis and Its Relation to Plasma Haemostatic Factors in Apparently Healthy Men - Role of the Metabolic Syndrome (1996) (88)
- Elevated levels of interleukin-6 in young adults with type 1 diabetes without clinical evidence of microvascular and macrovascular complications. (2001) (86)
- Association Between Diabetes and 1-Year Adverse Clinical Outcomes in a Multinational Cohort of Ambulatory Patients With Chronic Heart Failure: Results From the ESC-HFA Heart Failure Long-Term Registry (2017) (86)
- Serum uric acid and related factors in 500 hospitalized subjects. (1996) (85)
- The Use of Recombinant Activated FVII in Postpartum Hemorrhage (2010) (85)
- Elevated serum γ-glutamyltransferase activity is associated with increased risk of mortality, incident type 2 diabetes, cardiovascular events, chronic kidney disease and cancer – a narrative review (2010) (85)
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: is universal screening appropriate? (2016) (84)
- Nonalcoholic Fatty Liver Disease Is Associated With Ventricular Arrhythmias in Patients With Type 2 Diabetes Referred for Clinically Indicated 24-Hour Holter Monitoring (2016) (83)
- Tests for diagnosing and monitoring non-alcoholic fatty liver disease in adults (2018) (81)
- Association Between Primary Hypothyroidism and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. (2018) (81)
- The white blood cell count: its relationship to plasma insulin and other cardiovascular risk factors in healthy male individuals (1996) (80)
- Prognostic Impact of Diabetes on Long-term Survival Outcomes in Patients With Heart Failure: A Meta-analysis (2017) (79)
- Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis. (2008) (79)
- Prevalence of neuropathy in type 2 diabetic patients and its association with other diabetes complications: The Verona Diabetic Foot Screening Program. (2015) (78)
- Nonalcoholic Fatty Liver Disease Is Independently Associated with Early Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes (2015) (77)
- Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease (2015) (77)
- Relationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis? (2016) (76)
- Glycated hemoglobin (HbA1c): old dogmas, a new perspective? (2010) (76)
- Epidemiological Association between Uric Acid Concentration in Plasma, Lipoprotein(a), and the Traditional Lipid Profile (2010) (75)
- Immune tolerance with rituximab in congenital haemophilia with inhibitors: a systematic literature review based on individual patients’ analysis (2008) (74)
- Synbiotic Alters Fecal Microbiomes, but not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Non-alcoholic Fatty Liver Disease. (2020) (74)
- Global multi-stakeholder endorsement of the MAFLD definition. (2022) (74)
- Risk of type 2 diabetes in patients with non-alcoholic fatty liver disease: Causal association or epiphenomenon? (2016) (73)
- Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes. (2014) (73)
- Association between nonalcoholic fatty liver disease and colorectal tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis. (2018) (73)
- Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies (2021) (72)
- Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis? (2016) (72)
- Association between Nonalcoholic Liver Disease and Chronic Kidney Disease: An Ultrasound Analysis from NHANES 1988–1994 (2012) (72)
- Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link? (2015) (71)
- Heart valve calcification in patients with type 2 diabetes and nonalcoholic fatty liver disease. (2015) (71)
- Vitamin D, Thrombosis, and Hemostasis: More than Skin Deep (2012) (71)
- A "systems medicine" approach to the study of non-alcoholic fatty liver disease. (2016) (68)
- Hemostatic abnormalities in endocrine and metabolic disorders. (2010) (67)
- 25-Hydroxyvitamin D Deficiency and Inflammation and Their Association with Hemoglobin Levels in Chronic Kidney Disease (2009) (67)
- Hyperuricaemia: relationships to body fat distribution and other components of the insulin resistance syndrome in 38-year-old healthy men and women. (1995) (67)
- Hyperthyroidism and Venous Thrombosis: A Casual or Causal Association? A Systematic Literature Review (2011) (66)
- Variability of body weight, pulse pressure and glycaemia strongly predict total mortality in elderly type 2 diabetic patients. The Verona Diabetes Study (2008) (65)
- Laboratory, clinical and therapeutic aspects of acquired hemophilia A. (2008) (64)
- Association between serum TSH, free T4 and serum liver enzyme activities in a large cohort of unselected outpatients (2008) (64)
- Aortic and Mitral Annular Calcifications Are Predictive of All-Cause and Cardiovascular Mortality in Patients With Type 2 Diabetes (2012) (64)
- Glycated Haemoglobin Is Inversely Related to Serum Vitamin D Levels in Type 2 Diabetic Patients (2013) (63)
- Relation of elevated serum uric acid levels to incidence of atrial fibrillation in patients with type 2 diabetes mellitus. (2013) (63)
- Increased prevalence of chronic kidney disease in patients with Type 1 diabetes and non‐alcoholic fatty liver (2012) (62)
- The metabolic syndrome and the risk of arterial and venous thrombosis. (2008) (62)
- PNPLA3 rs738409 is associated with renal glomerular and tubular injury in NAFLD patients with persistently normal ALT levels (2020) (62)
- Low 25-hydroxyvitamin D level is independently associated with non-alcoholic fatty liver disease. (2013) (61)
- NAFLD in Some Common Endocrine Diseases: Prevalence, Pathophysiology, and Principles of Diagnosis and Management (2019) (61)
- Serum bilirubin levels and cardiovascular disease risk: a Janus Bifrons? (2010) (61)
- Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity. (2020) (61)
- Effect of lovastatin on primary prevention of cardiovascular events in mild CKD and kidney function loss: a post hoc analysis of the Air Force/Texas Coronary Atherosclerosis Prevention Study. (2010) (60)
- Plasma PAI-1 Levels Are Increased in Patients With Nonalcoholic Steatohepatitis (2007) (60)
- Relationship between serum gamma-glutamyltransferase and chronic kidney disease in the United States adult population. Findings from the National Health and Nutrition Examination Survey 2001-2006. (2010) (59)
- Pathogenesis, clinical and laboratory aspects of thrombosis in cancer (2007) (59)
- Predictors of insulin sensitivity in Type 2 diabetes mellitus (2002) (58)
- Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease (2021) (58)
- Relation between soluble adhesion molecules and insulin sensitivity in type 2 diabetic individuals: role of adipose tissue. (2001) (58)
- The effect of iron depletion on chronic hepatitis C virus infection (2008) (57)
- Effect of moderate aerobic exercise on sympatho‐vagal balance in Type 2 diabetic patients (2007) (57)
- Prevalence of Cardiovascular Autonomic Neuropathy in a Cohort of Patients With Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) (2015) (57)
- Disorders of coagulation and hemostasis in abdominal obesity: emerging role of fatty liver. (2010) (56)
- Efficacy and safety of anti-hyperglycaemic drugs in patients with non-alcoholic fatty liver disease with or without diabetes: an updated systematic review of randomized controlled trials. (2020) (55)
- High-Normal HbA1c Is a Strong Predictor of Type 2 Diabetes in the General Population (2011) (55)
- Vaccination, squalene and anti-squalene antibodies: facts or fiction? (2010) (54)
- Vitamin D, Parathyroid Hormone Levels, and the Prevalence of Metabolic Syndrome in Community-Dwelling Older Adults (2007) (54)
- Non-alcoholic fatty liver disease is independently associated with left ventricular hypertrophy in hypertensive Type 2 diabetic individuals (2012) (53)
- Nonalcoholic Fatty Liver Disease Is Associated with Aortic Valve Sclerosis in Patients with Type 2 Diabetes Mellitus (2014) (53)
- Erythrocyte mechanical fragility is increased in patients with type 2 diabetes. (2012) (52)
- Higher HDL cholesterol levels are associated with a lower incidence of chronic kidney disease in patients with type 2 diabetes. (2009) (52)
- Association between non‐alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: An updated meta‐analysis (2019) (51)
- Association between 25-hydroxyvitamin D deficiency and cardiovascular disease in type 2 diabetic patients with mild kidney dysfunction. (2007) (51)
- Acquired factor VIII inhibitors in oncohematology: a systematic review. (2008) (50)
- Psychological distress, self-efficacy and glycemic control in type 2 diabetes. (2017) (50)
- Circulating Markers of Liver Function and Cardiovascular Disease Risk (2015) (50)
- Moderate alcohol consumption and its relation to visceral fat and plasma androgens in healthy women. (1996) (50)
- Diagnosis and Management of Nonalcoholic Fatty Liver Disease and Its Hemostatic/Thrombotic and Vascular Complications (2013) (50)
- Relationship of serum bilirubin concentrations to kidney function and albuminuria in the United States adult population. Findings from the National Health and Nutrition Examination Survey 2001–2006 (2009) (50)
- Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular disease in adult patients with type 1 diabetes. (2016) (50)
- Fasting serum insulin in relation to components of the metabolic syndrome in European healthy men: the European Fat Distribution Study. (1995) (50)
- Global epidemiology of lean non‐alcoholic fatty liver disease: A systematic review and meta‐analysis (2020) (49)
- Hemophilia and cancer: a new challenge for hemophilia centers. (2009) (49)
- NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment. (2020) (49)
- Prevalence of thyroid autoimmunity and subclinical hypothyroidism in persons with chronic kidney disease not requiring chronic dialysis (2009) (47)
- Effect of simvastatin on kidney function loss in patients with coronary heart disease: findings from the Scandinavian Simvastatin Survival Study (4S). (2009) (47)
- Lower levels of 25-hydroxyvitamin D3 are associated with a higher prevalence of microvascular complications in patients with type 2 diabetes (2015) (47)
- Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease (2021) (47)
- Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post‐Hoc Analysis of the GISSI‐HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca‐Heart Failure) Trial (2017) (47)
- Sodium-Glucose Cotransporter-2 Inhibitors for Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials (2020) (46)
- Interpatient phenotypic inconsistency in severe congenital hemophilia: a systematic review of the role of inherited thrombophilia. (2009) (46)
- Liver fibrosis by FibroScan® independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes (2020) (46)
- Epidemiological association between fasting plasma glucose and shortened APTT. (2009) (45)
- Relationships of plasminogen activator inhibitor-1 to anthropometry, serum insulin, triglycerides and adipose tissue fatty acids in healthy men. (1994) (45)
- Reduced von Willebrand factor-cleaving protease levels in secondary thrombotic microangiopathies and other diseases. (2007) (45)
- Elevated Plasma Levels of Soluble Receptors of TNF-α and Their Association with Smoking and Microvascular Complications in Young Adults with Type 1 Diabetes (2001) (45)
- Clinical relevance of liver histopathology and different histological classifications of NASH in adults (2018) (43)
- Hyperuricemia in patients with chronic plaque psoriasis. (2014) (43)
- Nonalcoholic fatty liver disease is associated with an increased prevalence of distal symmetric polyneuropathy in adult patients with type 1 diabetes. (2017) (43)
- Genetic and biochemical heterogeneity of cardiac troponins: clinical and laboratory implications (2009) (42)
- Association of metabolic dysfunction-associated fatty liver disease with kidney disease (2022) (42)
- Incorporating fatty liver disease in multidisciplinary care and novel clinical trial designs for patients with metabolic diseases. (2021) (42)
- Relation of serum phosphorus levels to ankle brachial pressure index (from the Third National Health and Nutrition Examination Survey). (2010) (42)
- Is fasting glucose variability a risk factor for retinopathy in people with type 2 diabetes? (2009) (42)
- Association between hepatic steatosis and serum liver enzyme levels with atrial fibrillation in the general population: The Study of Health in Pomerania (SHIP). (2016) (41)
- Retinopathy Predicts Future Cardiovascular Events Among Type 2 Diabetic Patients (2006) (41)
- What’s new in NAFLD pathogenesis, biomarkers and treatment? (2019) (40)
- Nonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failure (2017) (40)
- Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic review (2022) (39)
- Mortality from infectious diseases in diabetes. (2018) (39)
- Obesity: Metabolically healthy obesity and NAFLD (2016) (39)
- Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection—Liver: The “Musketeer” in the Spotlight (2016) (39)
- Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. (2010) (39)
- Cigarette smoking and plasma total homocysteine levels in young adults with type 1 diabetes. (2000) (38)
- Relationship Between PNPLA3 rs738409 Polymorphism and Decreased Kidney Function in Children With NAFLD (2019) (38)
- Factors associated with significant liver steatosis and fibrosis as assessed by transient elastography in patients with one or more components of the metabolic syndrome. (2016) (37)
- Hyperthyroidism is associated with shortened APTT and increased fibrinogen values in a general population of unselected outpatients (2009) (37)
- Time to Replace Assessment of Liver Histology With MR-Based Imaging Tests to Assess Efficacy of Interventions for Nonalcoholic Fatty Liver Disease. (2016) (37)
- Anaemia, independent of chronic kidney disease, predicts all-cause and cardiovascular mortality in type 2 diabetic patients. (2010) (37)
- Serum 25-Hydroxyvitamin D 3 Concentrations and Prevalence of Cardiovascular Disease Among Type 2 Diabetic Patients (2006) (37)
- Pathogenesis of hypothyroidism-induced NAFLD: Evidence for a distinct disease entity? (2019) (37)
- Association of inflammation with anaemia in patients with chronic kidney disease not requiring chronic dialysis. (2008) (37)
- Sudden cardiac death: Prevalence, pathogenesis, and prevention (2008) (36)
- Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus (2017) (36)
- Increased aortic pulse wave velocity as measured by echocardiography is strongly associated with poor prognosis in patients with heart failure. (2013) (36)
- The aspartate aminotransferase-to-alanine aminotransferase ratio predicts all-cause and cardiovascular mortality in patients with type 2 diabetes (2016) (36)
- Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes. (2019) (34)
- Detrimental effects of metabolic dysfunction-associated fatty liver disease and increased neutrophil-to-lymphocyte ratio on severity of COVID-19 (2020) (34)
- Pancreatic fat accumulation and its relationship with liver fat content and other fat depots in obese individuals (2011) (34)
- Prognostic impact of in-hospital hyperglycemia in hospitalized patients with acute heart failure: Results of the IN-HF (Italian Network on Heart Failure) Outcome registry. (2016) (34)
- Diabetic retinopathy is associated with an increased incidence of cardiovascular events in Type 2 diabetic patients (2008) (34)
- Contribution of a genetic risk score to clinical prediction of hepatic steatosis in obese children and adolescents. (2019) (33)
- Hypoadiponectinemia is closely associated with nonalcoholic hepatic steatosis in obese subjects. (2004) (33)
- Abnormal serum alanine aminotransferase levels are associated with impaired insulin sensitivity in young women with polycystic ovary syndrome. (2009) (33)
- Association between Helicobacter pylori infection and risk of nonalcoholic fatty liver disease: An updated meta-analysis. (2019) (32)
- Screening for non-alcoholic fatty liver disease using liver stiffness measurement and its association with chronic kidney disease and cardiovascular complications in patients with type 2 diabetes. (2019) (32)
- Dark chocolate: consumption for pleasure or therapy? (2009) (32)
- The role of serum uric acid in cardiovascular disease in Type 2 diabetic and non-diabetic subjects: A narrative review (2011) (31)
- Plasma fibrinogen in relation to serum insulin, smoking habits and adipose tissue fatty acids in healthy men (1994) (31)
- Increased red blood cell distribution width (RDW) is associated with higher glycosylated hemoglobin (HbA1c) in the elderly. (2014) (31)
- The mean platelet volume is significantly associated with higher glycated hemoglobin in a large population of unselected outpatients. (2015) (31)
- Relationship between thyroid status and renal function in a general population of unselected outpatients. (2008) (31)
- Stereotactic body radiotherapy for lung oligometastases impacts on systemic treatment-free survival: a cohort study (2018) (31)
- Glomerular filtration rate, albuminuria and risk of cardiovascular and all-cause mortality in type 2 diabetic individuals. (2010) (31)
- Increased prevalence of cardiovascular disease in Type 1 diabetic patients with non-alcoholic fatty liver disease (2011) (30)
- Nonalcoholic Fatty Liver Disease: A Novel Cardiometabolic Risk Factor for Type 2 Diabetes and Its Complications (2013) (30)
- Relationship of nonalcoholic hepatic steatosis to overnight low‐dose dexamethasone suppression test in obese individuals (2004) (30)
- Hyperuricemia is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes (2016) (30)
- Associations between liver histology and carotid intima-media thickness in patients with nonalcoholic fatty liver disease. (2005) (30)
- Prognostic impact of elevated serum uric acid levels on long-term outcomes in patients with chronic heart failure: A post-hoc analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) trial. (2018) (30)
- Increase in Circulating Products of Lipid Peroxidation in Smokers With IDDM (1996) (30)
- Hemostatic disorders in type 1 diabetes mellitus. (2011) (30)
- A Perspective on Metabolic Syndrome and Nonalcoholic Fatty Liver Disease. (2015) (30)
- "Not all forms of NAFLD were created equal". Do metabolic syndrome-related NAFLD and PNPLA3-related NAFLD exert a variable impact on the risk of early carotid atherosclerosis? (2017) (29)
- Anaphylaxis in patients with congenital bleeding disorders and inhibitors (2009) (29)
- Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis (2021) (29)
- Cardiovascular risk profile in 38-year and 18-year-old men. Contribution of body fat content and regional fat distribution. (1996) (29)
- Venous thromboembolism in chronic liver disease. (2011) (28)
- Systematic review with meta‐analysis: non‐alcoholic fatty liver disease is associated with a history of osteoporotic fractures but not with low bone mineral density (2019) (28)
- Prophylaxis in von Willebrand disease (2007) (28)
- Effect of hemodialysis on traditional and innovative cardiac markers (2008) (28)
- Extra-skeletal effects of vitamin D deficiency in chronic kidney disease (2011) (28)
- Association Between Nonalcoholic Fatty Liver Disease and Reduced Bone Mineral Density in Children: A Meta‐Analysis (2019) (27)
- Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes. (2010) (27)
- Relationships of blood pressure to fibrinolysis: influence of anthropometry, metabolic profile and behavioural variables (1995) (27)
- Association between PNPLA3rs738409 polymorphism decreased kidney function in postmenopausal type 2 diabetic women with or without non-alcoholic fatty liver disease. (2019) (27)
- Black esophagus syndrome associated with diabetic ketoacidosis. (2016) (27)
- Relationship between γ-glutamyltransferase, lipids and lipoprotein(a) in the general population (2007) (27)
- Non-alcoholic fatty liver disease and increased risk of all-cause mortality in elderly patients admitted for acute heart failure. (2018) (27)
- Prevalence of prediabetes and diabetes in children and adolescents with biopsy-proven nonalcoholic fatty liver disease. (2019) (26)
- Optimal therapy for reduction of lipoprotein(a) (2012) (26)
- Nonalcoholic fatty liver disease and reduced serum vitamin D(3) levels. (2013) (26)
- Associations between specific plasma ceramides and severity of coronary-artery stenosis assessed by coronary angiography. (2020) (26)
- Effect of PNPLA3 polymorphism on diagnostic performance of various noninvasive markers for diagnosing and staging nonalcoholic fatty liver disease (2020) (26)
- Usefulness of subclinical left ventricular midwall dysfunction to predict cardiovascular mortality in patients with type 2 diabetes mellitus. (2014) (25)
- Associations between liver histology and early carotid atherosclerosis in subjects with nonalcoholic fatty liver disease (2005) (25)
- Relationship Between Abnormal Microvolt T‐Wave Alternans and Poor Glycemic Control in Type 2 Diabetic Patients (2007) (25)
- Prevention and treatment of nonalcoholic fatty liver disease. (2010) (25)
- Vitamin D deficiency among Italian children (2007) (25)
- Extracorporeal immunoadsorption for the treatment of coagulation inhibitors. (2009) (25)
- Relationship of non‐alcoholic hepatic steatosis to cortisol secretion in diet‐controlled Type 2 diabetic patients (2005) (24)
- Comparison of Two Creatinine-Based Estimating Equations in Predicting All-Cause and Cardiovascular Mortality in Patients With Type 2 Diabetes (2012) (24)
- Understanding the association between developing a fatty liver and subsequent cardio-metabolic complications (2015) (24)
- Association of Plasma Ceramides With Myocardial Perfusion in Patients With Coronary Artery Disease Undergoing Stress Myocardial Perfusion Scintigraphy (2018) (24)
- PNPLA3 I148M gene variant and chronic kidney disease in type 2 diabetic patients with NAFLD: Clinical and experimental findings (2020) (23)
- Risk of cardiovascular disease and chronic kidney disease in diabetic patients with non-alcoholic fatty liver disease: Just a coincidence? (2011) (23)
- Non‐alcoholic fatty liver disease‐related risk of cardiovascular disease and other cardiac complications (2021) (23)
- Combined and sequential non-invasive approach to diagnosing non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease and persistently normal alanine aminotransferase levels (2020) (23)
- A laboratory standpoint on the role of hemoglobin A1c for the diagnosis of diabetes in childhood: more doubts than certainties? (2011) (23)
- Relationship of Serum γ‐Glutamyltransferase to Atherogenic Dyslipidemia and Glycemic Control in Type 2 Diabetes (2009) (22)
- Association between non-alcoholic fatty liver disease and decreased lung function in adults: A systematic review and meta-analysis. (2019) (22)
- Concordance between MAFLD and NAFLD diagnostic criteria in ‘real‐world’ data (2020) (22)
- Monitoring glycaemic control: is there evidence for appropriate use of routine measurement of glycated haemoglobin? (2007) (22)
- The use of recombinant factor VIIa in liver diseases (2008) (22)
- Relationship between fasting insulin and cardiovascular risk factors is already present in young men: the Verona Young Men Atherosclerosis Risk Factors Study (1997) (21)
- Subclinical Acute Kidney Injury in COVID-19 Patients: A Retrospective Cohort Study (2020) (21)
- Low-grade endotoxemia, gut permeability and platelet activation in patients with impaired fasting glucose. (2017) (21)
- Early impairment in left ventricular longitudinal systolic function is associated with an increased risk of incident atrial fibrillation in patients with type 2 diabetes. (2017) (21)
- Usefulness of the triglyceride to high-density lipoprotein cholesterol ratio for predicting mortality risk in type 2 diabetes: role of kidney dysfunction. (2010) (21)
- The significance of evaluating conventional inflammatory markers in Von Willebrand factor measurement. (2007) (21)
- The red blood cell distribution width is associated with serum levels of thyroid stimulating hormone in the general population (2009) (21)
- Chronic cigarette smoking is associated with increased plasma circulating intercellular adhesion molecule 1 levels in young type 1 diabetic patients. (1999) (21)
- Effect of metformin on all-cause mortality and major adverse cardiovascular events: An updated meta-analysis of randomized controlled trials. (2020) (20)
- Screening and therapeutic management of lipoprotein(a) excess: review of the epidemiological evidence, guidelines and recommendations. (2011) (20)
- Relationship between serum phosphate and cardiovascular risk factors in a large cohort of adult outpatients. (2009) (20)
- Tomatoes, lycopene-containing foods and cancer risk (2011) (20)
- Mitral Regurgitation and Increased Risk of All-Cause and Cardiovascular Mortality in Patients with Type 2 Diabetes. (2017) (20)
- Hyperuricemia is associated with an increased prevalence of paroxysmal atrial fibrillation in patients with type 2 diabetes referred for clinically indicated 24-h Holter monitoring (2018) (20)
- Measurement of microvolt T‐wave alternans, a new arrhythmic risk stratification test, in Type 2 diabetic patients without clinical cardiovascular disease (2006) (20)
- Higher liver stiffness scores are associated with early kidney dysfunction in patients with histologically proven non-cirrhotic NAFLD. (2019) (19)
- Increased Pulse Pressure Independently Predicts Incident Atrial Fibrillation in Patients With Type 2 Diabetes (2012) (19)
- Determinants of anaemia in the very elderly: a major contribution from impaired renal function? (2010) (19)
- Antithrombotic prophylaxis in patients with von Willebrand disease undergoing major surgery: when is it necessary? (2009) (19)
- Plasma Leptin in Patients at Intermediate to High Cardiovascular Risk With and Without Type 2 Diabetes Mellitus (2017) (19)
- Elevated plasma levels of soluble receptors of TNF-alpha and their association with smoking and microvascular complications in young adults with type 1 diabetes. (2001) (19)
- Association and Interaction Between Serum Interleukin-6 Levels and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients With Severe Coronavirus Disease 2019 (2021) (19)
- The International Diabetes Federation definition of the metabolic syndrome independently predicts future cardiovascular events in Type 2 diabetic patients. The Valpolicella Heart Diabetes Study (2006) (19)
- Hemostatic and Fibrinolytic Abnormalities in Polycystic Ovary Syndrome (2014) (18)
- Plasma N‐terminal propeptide of type III procollagen accurately predicts liver fibrosis severity in children with non‐alcoholic fatty liver disease (2019) (18)
- Prevalence of Folic Acid and Vitamin B12 Deficiencies in Patients With Thyroid Disorders (2008) (18)
- Relationship between serum bilirubin and kidney function in non-diabetic and diabetic individuals. (2009) (18)
- Nonalcoholic fatty liver disease in patients with chronic plaque psoriasis. (2009) (18)
- Non-alcoholic fatty liver disease as a determinant of cardiovascular disease. (2007) (17)
- Prevalence of diabetes across different immigrant groups in North-eastern Italy. (2015) (17)
- Risk of all-cause and cardiovascular mortality in patients with chronic liver disease (2010) (17)
- Ultrasonographic intra-abdominal depth and its relation to haemostatic factors in healthy males. (1996) (17)
- Plasma total homocysteine levels are associated with von Willebrand factor, soluble intercellular adhesion molecule-1, and soluble tumor necrosis factor-alpha receptors in young type 1 diabetic patients without clinical evidence of macrovascular complications. (2001) (17)
- Evidence of left atrial remodeling and left ventricular diastolic dysfunction in type 2 diabetes mellitus with preserved systolic function. (2016) (16)
- NAFLD-related mortality: simple hepatic steatosis is not as ‘benign’ as thought (2020) (16)
- Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease (2011) (16)
- Diagnostic accuracy of ultrasonography for the detection of hepatic steatosis: an updated meta-analysis of observational studies (2021) (16)
- Procalcitonin values after dialysis is closely related to type of dialysis membrane (2009) (16)
- Effect of chronic treatment with lacidipine or lisinopril on intracellular partitioning of glucose metabolism in type 2 diabetes mellitus. (1999) (16)
- Abnormal liver enzymes in children and infants with COVID‐19: A narrative review of case‐series studies (2020) (15)
- Non-alcoholic fatty liver disease and estimated insulin resistance in obese youth: a Mendelian randomization analysis. (2020) (15)
- Troponin in Stable Ischemic Heart Disease and Diabetes. (2015) (15)
- Pasireotide in Cushing's disease. (2012) (15)
- Association between increased plasma ceramides and chronic kidney disease in patients with and without ischemic heart disease. (2020) (15)
- Relationship between gamma-glutamyltransferase, lipids and lipoprotein(a) in the general population. (2007) (15)
- Association between plasma ceramides and inducible myocardial ischemia in patients with established or suspected coronary artery disease undergoing myocardial perfusion scintigraphy. (2018) (15)
- Inappropriate left ventricular mass independently predicts cardiovascular mortality in patients with type 2 diabetes. (2013) (15)
- Nonalcoholic Fatty Liver Disease and Cardiovascular Disease (2021) (15)
- Relationship Between Early Diastolic Dysfunction and Abnormal Microvolt T-Wave Alternans in Patients With Type 2 Diabetes (2011) (14)
- Hypovitaminosis D among unselected medical inpatients and outpatients in Northern Italy (2006) (14)
- Intracellular partition of plasma glucose disposal in hypertensive and normotensive subjects with type 2 diabetes mellitus. (2001) (14)
- Nonalcoholic Fatty Liver Disease Is Associated With Higher 1-year All-Cause Rehospitalization Rates in Patients Admitted for Acute Heart Failure (2016) (14)
- Ginkgo biloba, inflammation and lipoprotein(a). (2007) (14)
- Metabolic Dysfunction-associated Fatty Liver Disease is Associated with Greater Impairment of Lung Function than Nonalcoholic Fatty Liver Disease (2022) (13)
- Intimal-medial thickness of the carotid artery in nondiabetic and non-insulin-dependent diabetic subjects. Relationship with insulin resistance. (1997) (13)
- Risk of ischemic stroke and decreased serum bilirubin levels: is there a causal link? (2014) (13)
- ACE2: A Linkage for the Interplay Between COVID-19 and Decompensated Cirrhosis (2020) (12)
- Eosinophilia and first-line coagulation testing (2009) (12)
- Relationship between serum gamma-glutamyltransferase concentrations and chronic kidney disease in the United States population. Findings from the National Health and Nutrition Examination Survey 2001-2006. (2010) (12)
- Hemostatic and fibrinolytic abnormalities in endocrine diseases: a narrative review. (2009) (12)
- Influence of hypertriglyceridemia, hyperbilirubinemia and hemolysis on thrombin generation in human plasma (2019) (12)
- Is Nonalcoholic Fatty Liver Disease Not a Risk Factor for Cardiovascular Disease: Not Yet Time for a Change of Heart (2020) (12)
- Soluble CD40L in young type 1 diabetic individuals without clinical microvascular and macrovascular complications. (2004) (12)
- Effect of insulin secretagogues on major cardiovascular events and all-cause mortality: A meta-analysis of randomized controlled trials. (2020) (12)
- Lipoprotein(a) and ageing. (2010) (12)
- Severe hypoglycemia in patients with known diabetes requiring emergency department care: A report from an Italian multicenter study (2016) (11)
- Plasma Bile Acid Profile in Patients with and without Type 2 Diabetes (2021) (11)
- Development and validation of a novel non‐invasive test for diagnosing fibrotic non‐alcoholic steatohepatitis in patients with biopsy‐proven non‐alcoholic fatty liver disease (2020) (11)
- Relationship between gamma-glutamyltransferase, fasting plasma glucose, and triglycerides in the general population. (2007) (11)
- Adiponectin and migraine: systematic review of clinical evidence (2014) (11)
- Non-alcoholic fatty liver disease in obese children and adolescents: a role for nutrition? (2021) (11)
- Non-alcoholic fatty liver disease is a risk factor for cardiovascular and cardiac diseases: further evidence that a holistic approach to treatment is needed (2021) (11)
- Lower 25-hydroxyvitamin D3 levels and increased risk of liver diseases: is there a causal link? (2014) (11)
- Vitamin B12, folate, and anemia in old age. (2009) (11)
- Relationship between increased left atrial volume and microvascular complications in patients with type 2 diabetes. (2015) (11)
- Effect of aspirin on renal disease progression in patients with type 2 diabetes: A multicenter, double-blind, placebo-controlled, randomized trial. The renaL disEase progression by aspirin in diabetic pAtients (LEDA) trial. Rationale and study design. (2017) (11)
- Risk of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis: an updated systematic review and meta-analysis of observational studies (2022) (11)
- acNASH index to diagnose nonalcoholic steatohepatitis: a prospective derivation and global validation study (2021) (10)
- Improvement of glycemic control in type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials. (2021) (10)
- Echocardiographically Derived Pulse Wave Velocity and Diastolic Dysfunction Are Associated with an Increased Incidence of Atrial Fibrillation in Patients with Systolic Heart Failure (2016) (10)
- Precision medicine approaches in metabolic disorders and target organ damage: where are we now, and where are we going? (2021) (10)
- Relationship of hepatic steatosis and alanine aminotransferase with coronary calcification (2011) (10)
- Gallstone Disease and Increased Risk of Ischemic Heart Disease: Causal Association or Epiphenomenon? (2015) (10)
- Prospective evaluation of non-alcoholic fatty liver disease by elastographic methods of liver steatosis and fibrosis; controlled attenuation parameter and liver stiffness measurements. (2019) (10)
- Association between MBOAT7 rs641738 polymorphism and non-alcoholic fatty liver in overweight or obese children. (2021) (10)
- The E/e’ ratio difference between subjects with type 2 diabetes and controls. A meta-analysis of clinical studies (2018) (10)
- The effect of combined calcium and cholecalciferol supplementation on bone mineral density in elderly women with moderate chronic kidney disease (2011) (10)
- Non-alcoholic fatty liver disease as driving force in coronary heart disease? (2016) (9)
- Bilirubin concentration and cardiovascular risk profile (2009) (9)
- Commentary: Liver enzymes and the risk of adverse cardiovascular outcomes--the lower, the better? (2011) (9)
- Obesity worsens cardiovascular risk profiles independently of hyperinsulinaemia (1997) (9)
- Among simple non-invasive scores, Pro-C3 and ADAPT best exclude advanced fibrosis in Asian patients with MAFLD. (2021) (9)
- A fatty liver leads to decreased kidney function? (2017) (9)
- Relation of elevated serum uric acid levels to first-degree heart block and other cardiac conduction defects in hospitalized patients with type 2 diabetes. (2017) (9)
- Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention (2022) (9)
- Relationship between Mean Platelet Volume and Biochemical Components of the Metabolic Syndrome (2007) (9)
- NAFLD: Is There Anything New under the Sun? (2017) (9)
- Relation between plasma ceramides and cardiovascular death in chronic heart failure: A subset analysis of the GISSI‐HF trial (2020) (9)
- Long-Acting GLP-1 Receptor Agonist Exenatide Influence on the Autonomic Cardiac Sympatho-Vagal Balance (2017) (9)
- Optimal thresholds for ultrasound attenuation parameter in the evaluation of hepatic steatosis severity: evidence from a cohort of patients with biopsy-proven fatty liver disease. (2020) (8)
- Biochemical correlates of lipoprotein(a) in a general adult population. Possible implications for cardiovascular risk assessment (2007) (8)
- Abnormal serum alanine aminotransferase levels are associated with impaired insulin sensitivity in young women with polycystic ovary syndrome (2009) (8)
- The cost-benefit ratio of screening pregnant women for thrombophilia. (2007) (8)
- Inherited and acquired risk factors for arterial ischemic stroke in childhood (2009) (8)
- NAFLD fibrosis score (NFS) can be used in outpatient services to identify chronic vascular complications besides advanced liver fibrosis in type 2 diabetes. (2020) (8)
- Is COVID-19 lockdown associated with vitamin D deficiency? (2021) (8)
- FNDC5 polymorphism influences the association between sarcopenia and liver fibrosis in adults with biopsy-proven non-alcoholic fatty liver disease (2020) (8)
- Lower levels of plasma NT-proBNP are associated with higher prevalence of NASH in patients with biopsy-proven NAFLD. (2020) (8)
- Plasma gamma-glutamyl transferase activity predicts homocysteine concentration in a large cohort of unselected outpatients. (2008) (7)
- Association between specific plasma ceramides and high-sensitivity C-reactive protein levels in postmenopausal women with type 2 diabetes. (2020) (7)
- Association between subclinical left ventricular systolic dysfunction and glycemic control in asymptomatic type 2 diabetic patients with preserved left ventricular function. (2017) (7)
- Human and molecular genetics shed lights on fatty liver disease and diabetes conundrum (2020) (7)
- [Role of biochemical risk factors and markers for the risk of atherosclerosis]. (2008) (7)
- Glucose challenge test does not predict gestational diabetes mellitus. (2008) (7)
- Serum leptin concentrations in young smokers with type 1 diabetes. (2001) (7)
- Association between non-alcoholic fatty liver disease and impaired cardiac sympathetic/parasympathetic balance in subjects with and without type 2 diabetes-The Cooperative Health Research in South Tyrol (CHRIS)-NAFLD sub-study. (2021) (7)
- Association between positivity of serum autoantibodies and liver disease severity in patients with biopsy-proven NAFLD. (2020) (7)
- Multiple biomarkers for the prediction of first major cardiovascular events and death: considerable costs and limited benefits. (2007) (7)
- Diffuse Idiopathic Skeletal Hyperostosis (DISH) in Type 2 Diabetes: A New Imaging Possibility and a New Biomarker (2020) (7)
- Ferroptosis and metabolic dysfunction‐associated fatty liver disease: Is there a link? (2022) (7)
- Lipoprotein(a), Thrombophilia and Venous Thrombosis (2007) (7)
- Relationship between uric acid, hyperglycemia and hypertriglyceridemia in general population (2008) (7)
- Beneficial effects of glucagon-like peptide 1 receptor agonists on glucose control, cardiovascular risk profile, and non-alcoholic fatty liver disease. An expert opinion of the Italian diabetes society. (2021) (7)
- Plasma factor VII and its relation to adipose tissue fatty acids and other atherogenic risk factors in healthy men (1996) (7)
- Non-alcoholic Fatty Liver Disease and Cardiovascular Disease Risk (2010) (7)
- Sex influences the association between appendicular skeletal muscle mass to visceral fat area ratio and non-alcoholic steatohepatitis in patients with biopsy-proven non-alcoholic fatty liver disease (2021) (7)
- From nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease: is it time for a change of terminology? (2020) (6)
- Significant liver fibrosis, as assessed by fibroscan, is independently associated with chronic vascular complications of type 2 diabetes: a multicenter study. (2021) (6)
- Plasma D-dimer in the diagnosis of acute aortic dissection. (2008) (6)
- Platelets and lipoprotein(a) in retinal vein occlusion: Mutual targets for aspirin therapy (2007) (6)
- High-sensitivity C-reactive protein, obesity, and subclinical atherosclerosis: implications of JUPITER from the MESA study. (2011) (6)
- Effect of serum gamma-glutamyltransferase and obesity on the risk of dyslipidemia and poor glycemic control in type 2 diabetic patients: cross-sectional findings from the Verona Diabetes Study. (2007) (6)
- Italian guidelines for the treatment of type 2 diabetes. (2022) (6)
- Smoking and Diabetes: how does smoking affect insulin sensitivity? (2005) (6)
- Increased aortic stiffness index in patients with type 1 diabetes without cardiovascular disease compared to controls (2019) (6)
- Detecting of chronic kidney disease in older people by the MDRD and MCQ formulas. (2008) (6)
- Growth differentiation factor-15 and the association between type 2 diabetes and liver fibrosis in NAFLD (2021) (6)
- Non-invasive fibrosis assessment in non-alcoholic fatty liver disease (2020) (6)
- Prevalence of hepatic steatosis in patients with type 2 diabetes and response to glucose-lowering treatments. A multicenter retrospective study in Italian specialist care (2021) (6)
- Associations of liver volume and other markers of hepatic steatosis with all‐cause mortality in the general population (2021) (6)
- Comparative effects of non-alcoholic fatty liver disease and metabolic dysfunction-associated fatty liver disease on risk of incident cardiovascular events: a meta-analysis of about 13 million individuals (2022) (6)
- The HSD17B13 rs72613567 variant is associated with lower levels of albuminuria in patients with biopsy-proven nonalcoholic fatty liver disease. (2021) (5)
- Treatment algorithm in patients with type 2 diabetes and atherosclerotic cardiovascular disease or high/very high cardiovascular risk. (2019) (5)
- Is it time for non-alcoholic fatty liver disease screening in patients with type 2 diabetes mellitus? (2020) (5)
- Effects of pioglitazone on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A meta-analysis of randomized controlled trials. (2021) (5)
- What’s Past Is Prologue: History of Nonalcoholic Fatty Liver Disease (2020) (5)
- Non-alcoholic fatty liver disease and risk of new-onset heart failure: an updated meta-analysis of about 11 million individuals (2022) (5)
- From a fatty liver to a sugary blood. (2018) (5)
- Further insights on the relationship between bilirubin and C-reactive protein (2012) (5)
- Estimating the real burden of cardiovascular mortality in diabetes. (2019) (5)
- Changes in markers of hepatic steatosis and fibrosis in patients with type 2 diabetes during treatment with glucagon-like peptide-1 receptor agonists. A multicenter retrospective longitudinal study. (2021) (5)
- A novel quantitative ultrasound technique for identifying non‐alcoholic steatohepatitis (2021) (4)
- Associations of Hydroxysteroid 17-beta Dehydrogenase 13 Variants with Liver Histology in Chinese Patients with Metabolic-associated Fatty Liver Disease (2021) (4)
- Individualized Polygenic Risk Score Identifies NASH in the Eastern Asia Region: A Derivation and Validation Study (2021) (4)
- Relationship between lipoprotein(a) and thyroid function status in the general population. (2007) (4)
- Random plasma glucose measurement may improve the diagnostic specificity of highly sensitive troponin in the emergency department. (2012) (4)
- Lifestyle Interventions for Non-Obese Patients Both with, and at Risk, of Non-Alcoholic Fatty Liver Disease (2022) (4)
- Tirzepatide adds hepatoprotection to its armoury. (2022) (4)
- Relationship between hypomagnesemia and glucose homeostasis. (2008) (4)
- Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO). (2021) (4)
- 73. Liver steatosis and its relation to haemostatic factors in healthy males (1996) (4)
- Polycystic Ovary Syndrome. (2016) (4)
- Hyperuricaemia is associated with increased C-reactive protein concentrations in a large cohort of unselected outpatients. (2008) (4)
- Retinopathy Predicts Cardiovascular Mortality in Type 2 Diabetic Men and Women (2007) (4)
- Detection of chronic kidney disease in hospitalized patients: is one estimating glomerular filtration rate equation better than another? (2011) (4)
- Impact of bariatric surgery-induced weight loss on circulating PCSK9 levels in obese patients. (2020) (4)
- Inflammatory variables may mediate the link between low plasma vitamin B6 concentrations and cardiovascular disease in type 2 diabetes. (2006) (4)
- Hypoglycemia Alert Dogs: A Novel, Cost-effective Approach for Diabetes Monitoring? (2016) (4)
- TA allele of rs2070673 in the CYP2E1 gene is associated with lobular inflammation and nonalcoholic steatohepatitis in patients with biopsy‐proven nonalcoholic fatty liver disease (2021) (4)
- Nonalcoholic fatty liver disease – a growing public health problem (2021) (4)
- Mo-P1:133 Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients (2006) (4)
- Ad Libitum Mediterranean or Low‐Fat Diets as Treatments for Nonalcoholic Fatty Liver Disease? (2018) (4)
- Management of type 2 diabetes for prevention of cardiovascular disease. An expert opinion of the Italian Diabetes Society. (2020) (4)
- Nonalcoholic Fatty Liver Disease and Implications for Older Adults with Diabetes. (2020) (4)
- Haemoglobin A1c and diagnosis of diabetes. Not ready for the prime time? (2012) (4)
- Association between lower plasma adiponectin levels and higher plasma thrombin generation parameters in men with type 2 diabetes: role of plasma triglycerides (2020) (4)
- Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO). (2021) (4)
- Old and new classes of glucose-lowering agents as treatments for non-alcoholic fatty liver disease: A narrative review (2022) (3)
- Editorial: importance of an elevated mean platelet volume for prediction of major adverse cardiovascular events in non‐alcoholic fatty liver disease (2019) (3)
- Visceral adipose tissue may mediate the link between non-alcoholic fatty liver disease and endocrine abnormalities. (2006) (3)
- Effects of insulin on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A meta-analysis of randomized controlled trials. (2022) (3)
- Mechanisms and possible hepatoprotective effects of glucagon-like peptide-1 receptor agonists and other incretin receptor agonists in non-alcoholic fatty liver disease. (2023) (3)
- Alanine aminotransferase as an independent predictor of incident nonalcoholic fatty liver disease. (2007) (3)
- Left ventricular chamber dilation and filling pressure may help to categorise patients with type 2 diabetes (2018) (3)
- Are we overrating the extra-skeletal benefits of oral vitamin D supplementation? (2019) (3)
- 72. Involvement of the haemostatic system in the insulin resistance syndrome (IRS) (1996) (3)
- GLP-1 receptor agonists for NAFLD treatment in patients with and without type 2 diabetes: an updated meta-analysis (2020) (3)
- A comparison between the HOMA model and the euglycemic clamp in the assessment of insulin sensitivity in vivo (1997) (3)
- PNPLA3 Polymorphism Influences The Association Between High-Normal Tsh Level And Nash In Euthyroid Adults With Biopsy-Proven Nafld. (2020) (3)
- Development and validation of a novel non-invasive test for diagnosing fibrotic NASH in patients with biopsy-proven NAFLD. (2020) (3)
- Low skeletal muscle mass is associated with more severe histological features of non-alcoholic fatty liver disease in male (2022) (3)
- High-Dose Vitamin D Supplementation and Bone Health. (2020) (3)
- Hepatocellular cystathionine γ lyase/hydrogen sulfide attenuates nonalcoholic fatty liver disease by activating farnesoid X receptor (2022) (3)
- Impact of reference category and number of traits in the cluster on risk of coronary heart disease in metabolic syndrome: prospective data from the Bruneck study. (2011) (3)
- Cardiovascular Risk in NAFLD: An Intimate Relationship? (2019) (3)
- Nonalcoholic fatty liver disease, cardiovascular outcomes, and mortality in patients undergoing a coronary angiogram (2015) (3)
- Association between lower plasma adiponectin levels and higher liver stiffness in type 2 diabetic individuals with nonalcoholic fatty liver disease: an observational cross-sectional study (2022) (3)
- Editorial: a diabetologist's perspective on the diagnosis and monitoring of NAFLD (2020) (3)
- Natriuretic peptides for assessing the prognosis of acute pulmonary embolism. (2008) (2)
- Uric acid concentration in patient with acute coronary syndrome (2008) (2)
- Further advices on measuring lipoprotein(a) for reducing the residual cardiovascular risk on statin therapy (2020) (2)
- Relationship between lipoprotein(a) and fasting plasma glucose in the general population (2007) (2)
- Sample stability for the measurement of hemoglobin A1c. (2010) (2)
- Relationship between serum vitamin D and inflammatory markers in the general population: comment on the article by Patel et al. (2008) (2)
- Coffee, Atrial Fibrillation, and Circulating Ceramides in Patients with Chronic Heart Failure. (2021) (2)
- A novel radiomics signature based on T2-weighted imaging accurately predicts hepatic inflammation in individuals with biopsy-proven nonalcoholic fatty liver disease: a derivation and independent validation study. (2021) (2)
- Relationship between soluble CD40 ligand and γ‐glutamyltransferase concentrations in non‐drinking, young Type 1 diabetic individuals (2008) (2)
- Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Clinical and Research Implications (2022) (2)
- Has homocysteine shrunk? (2007) (2)
- From nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease: more than a single-letter change in an acronym (2021) (2)
- Increased aortic stiffness in adults with chronic indeterminate Chagas disease (2019) (2)
- Safety of recombinant activated factor VII in randomized clinical trials. (2011) (2)
- Rivaroxaban for thromboprophylaxis. (2008) (2)
- Portal hypertension in nonalcoholic fatty liver disease: Challenges and perspectives (2022) (2)
- Non-Alcoholic Fatty Liver Disease Is Associated With Reduced Glomerular Filtration Rate in Patients With Chronic Plaque Psoriasis (2021) (2)
- Association between decreasing estimated glomerular filtration rate and risk of cardiac conduction defects in patients with type 2 diabetes. (2018) (2)
- Pioglitazone in nonalcoholic steatohepatitis. (2007) (2)
- Diagnostic significance of haematological testing in patients presenting at the Emergency Department (2012) (2)
- Editorial: higher levels of certain serum bile acids in non‐alcoholic fatty liver disease—new insights from Guatemala (2022) (2)
- Liver fat content, non-alcoholic fatty liver disease, and risk of ischaemic heart disease. (2018) (2)
- Association between higher serum uric acid levels and plasma N-terminal pro-B-type natriuretic peptide concentrations in patients with coronary artery disease and without overt heart failure. (2022) (2)
- Relationship between serum bilirubin and kidney function in non-diabetic and diabetic individuals. Authors' reply (2009) (2)
- J-shaped relationship between serum zinc levels and the severity of hepatic necro-inflammation in patients with MAFLD. (2022) (2)
- Could Targeted Pharmacotherapies Exert a “Disease Modification Effect” in Patients with Chronic Plaque Psoriasis? (2022) (2)
- Radiomics based on fluoro-deoxyglucose positron emission tomography predicts liver fibrosis in biopsy-proven MAFLD: a pilot study (2021) (2)
- Machine learning algorithms based on proteomic data mining accurately predicting the recurrence of hepatitis B‐related hepatocellular carcinoma (2022) (2)
- Italian guidelines for the treatment of type 2 diabetes (2022) (2)
- Inherited platelet disorders (Review). (2008) (2)
- Potential Blood DNA Methylation Biomarker Genes for Diagnosis of Liver Fibrosis in Patients With Biopsy-Proven Non-alcoholic Fatty Liver Disease (2022) (2)
- Does high LDL-cholesterol cause cardiovascular disease? (2018) (2)
- Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and Supraventricular and Ventricular Tachyarrhythmias in Patients with Type 2 Diabetes. (2022) (1)
- Time to consider a holistic approach to the treatment of non-alcoholic fatty liver disease in obese young people? (2022) (1)
- Comparison of cardiovascular mortality between MAFLD and NAFLD: A cohort study. (2023) (1)
- Low cardiopulmonary fitness is associated with higher liver fat content and higher gamma‐glutamyltransferase concentrations in the general population – “The Sedentary’s Liver” (2022) (1)
- Point-of-Care Testing for Measuring Hemoglobin A1c : Is It Really Worthwhile? Authors' reply (2008) (1)
- Non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis. (2021) (1)
- Basic and clinical science posters: Lipids and fatty liver (2019) (1)
- All-cause mortality and cardiovascular events in patients with type 2 diabetes treated with alpha-glucosidase inhibitors: A meta-analysis of randomized controlled trials. (2021) (1)
- All-cause mortality and cardiovascular events in patients with type 2 diabetes treated with alpha-glucosidase inhibitors: A meta-analysis of randomized controlled trials. (2021) (1)
- Arterial thrombus formation in cardiovascular (2011) (1)
- Pre-existing type 2 diabetes is associated with increased all-cause death independently of echocardiographic predictors of poor prognosis only in ischemic heart disease. (2020) (1)
- Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantation (2022) (1)
- The interaction of SAMM50-rs738491, PARVB-rs5764455 and PNPLA3-rs738409 increases the susceptibility to nonalcoholic steatohepatitis (2020) (1)
- We-P12:293 Associations between carotid artery wall thickness and liver histology in patients with non-alcoholic fatty liver disease (2006) (1)
- Effects of glucose‐lowering agents on cardiovascular and renal outcomes in subjects with type 2 diabetes: An updated meta‐analysis of randomized controlled trials with external adjudication of events (2022) (1)
- Long-Term Adverse Effect of Liver Stiffness on Glycaemic Control in Type 2 Diabetic Patients with Nonalcoholic Fatty Liver Disease: A Pilot Study (2022) (1)
- Telomerase: a key player in the pathogenesis of non-alcoholic fatty liver disease? (2021) (1)
- Secondary bile acids improve risk prediction for non‐invasive identification of mild liver fibrosis in nonalcoholic fatty liver disease (2023) (1)
- Diabetes and NAFLD (2020) (1)
- Lower serum copper concentrations are associated with higher prevalence of nonalcoholic steatohepatitis: a matched case–control study (2022) (1)
- Elastographic parameters of liver steatosis and fibrosis predict independently the risk of incident chronic kidney disease and acute myocardial infarction in patients with type 2 diabetes mellitus. (2022) (1)
- Relationship between albuminuria and hemoglobin level. (2009) (1)
- SAT-314-Liver fibrosis by FibroScan is highly prevalent in type 2 diabetic patients with NAFLD and fairly normal liver enzymes but increased uric acid (2019) (1)
- An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease (2023) (1)
- How does How does smoking affect smoking affect insulin sensitivity (2005) (1)
- Haemoglobin A 1 c and diagnosis of diabetes . Not ready for the prime time ? (2012) (1)
- Subclinical Myocardial Fibrosis in Systemic Lupus Erythematosus as Assessed by Pulse-Cancellation Echocardiography: A Pilot Study (2022) (1)
- Association between thyroid function and assessment of hepatic fat and iron contents by magnetic resonance imaging (2022) (1)
- [122] ANEMIA, INDEPENDENT OF CHRONIC KIDNEY DISEASE, PREDICTS ALL-CAUSE AND CARDIOVASCULAR MORTALITY IN TYPE 2 DIABETIC PATIENTS (2009) (1)
- Risks and benefits of replacing conventional plasma lipids with apolipoprotein measurement (2009) (1)
- Influence of age and gender variations on glomerular filtration rate estimated by the MCQE formula (2009) (1)
- Glucagon-like peptide-1 receptor agonists for treatment of nonalcoholic steatohepatitis: new insights from subcutaneous semaglutide. (2021) (1)
- Pharmacological treatment of moderate-severe psoriasis in patients with cardio-metabolic comorbidities (2014) (1)
- Nonalcoholic fatty liver disease and atherosclerosis. (2005) (1)
- NAFLD in the 20's. From Epidemiology to Pathogenesis and Management of Nonalcoholic Fatty Liver Disease. (2020) (1)
- Adverse effect of PNPLA3 p.I148M genetic variant on kidney function in middle‐aged individuals with metabolic dysfunction (2023) (1)
- Higher random plasma glucose level is associated with increased plasma cardiac troponin in emergency department patients with suspected acute coronary syndrome. (2012) (1)
- Glycemic control predicts the risk of hepatic fibrosis in biopsy-proven NAFLD: a possible mediating role for leukemia inhibitory factor? (2022) (1)
- “Buffalo” hump in nonalcoholic fatty liver disease (2007) (1)
- Association between PNPLA3 rs738409 variant and 5-year estimated glomerular filtration rate decline in post-menopausal women with type 2 diabetes: a panel-data analysis (2023) (1)
- Relationship between von Willebrand factor, cholesterol and triglycerides in non-diabetic subjects. (2008) (1)
- Role of biochemical risk factor and markers in the atherosclerosis process. (2008) (1)
- NAFLD and Cardiovascular Risk Factors: Implications for Vascular Disease (2013) (1)
- Serum LP(A) levels in randomized healthy men from different European countries (1993) (1)
- Type 2 Diabetes and Dietary Carbohydrate Intake of Adolescents and Young Adults: What Is the Impact of Different Choices? (2021) (0)
- Echocardiographic parameters according to insulin dose in young patients affected by type 1 diabetes (2020) (0)
- Prognostic Role of Pericardial Fat on the Incidence of Heart Failure. (2021) (0)
- Reply: To PMID 23504926. (2014) (0)
- Reply (2014) (0)
- Pulse pressure is a strong and independent predictor of incident atrial fibrillation in type 2 diabetic patients (2011) (0)
- SGLT2 inhibitors improve hepatic fibrosis assessed by Fibroscan in NAFLD patients with type 2 diabetes: A five-year follow-up study (2023) (0)
- Inflammatory interactions between nonalcoholic fatty liver disease and the metabolic syndrome (2006) (0)
- Inter-atrial shunt inversion by the sitting position in a patient with a patent foramen ovale and acute pulmonary embolism. (2014) (0)
- Serum prolactin in professional soccer players (2009) (0)
- The white blood cell count: Relationships to other cardiovascular risk factors in healthy men (1995) (0)
- Byrne and Targher NAFLD , Ectopic Fat , and CVD Risk 3 Epidemiological Evidence Linking NAFLD to CVD (0)
- Non-alcoholic Fatty Liver Disease and Increased Risk of 1-Year All-Cause 1 and Cardiac Hospital Readmissions in Elderly Patients Admitted for Acute 2 Heart Failure 3 4 (2017) (0)
- Fully connected neural network-based serum surface-enhanced Raman spectroscopy accurately identifies non-alcoholic steatohepatitis (2022) (0)
- Reply (2008) (0)
- Association between Higher Circulating Leucine-Rich α-2 Glycoprotein 1 Concentrations and Specific Plasma Ceramides in Postmenopausal Women with Type 2 Diabetes (2022) (0)
- Higher consumption of animal organ meat is associated with a lower prevalence of nonalcoholic steatohepatitis (2021) (0)
- Hypovitaminosis D among unselected in-patients and out-patients in northern Italy. (2006) (0)
- Obesity and Diabetes (2006) (0)
- Higher liver stiffness is associated with early kidney dysfunction in patients with histologically-proven non-cirrhotic NAFLD (2019) (0)
- Differential relationships between basal and post-load insulin resistance indices and hepatic fibrosis in chronic hepatitis C and in non-alcoholic fatty liver disease. (2008) (0)
- Association between hepatic iron overload assessed by magnetic resonance imaging and glucose intolerance states in the general population. (2022) (0)
- PRO-C3 based sequential algorithm can screen high-risk NASH and severe fibrosis in asian NAFLD population (2022) (0)
- Point-of-care testing for measuring hemoglobin A1c: is it really worthwhile? (2008) (0)
- Response to “NASH Predicts Plasma Inflammatory Biomarkers Independently of Visceral Fat in Men” (2009) (0)
- The use of recombinant factor VIIa in liver diseases. [Review] (2008) (0)
- Association of arterial hypertension with hepatic steatosis and fibrosis measured by transhepatic elastography with a controlled attenuation parameter (2017) (0)
- Basic and clinical science posters: Insulinotropic agents and enteroinsular hormones (2019) (0)
- Arm blood pressure index and lipoprotein(a) in renal transplant recipients. (2008) (0)
- Relationship between serum gamma- glutamyltransferase and chronic kidney disease in the United States adult population. Findings from the National Health and Nutrition Examination Survey 2001e2006 (2010) (0)
- Migraine, valproic acid and lipoprotein(a). [Letter] (2009) (0)
- Relationship between serum phosphate and traditional cardiovascular risk factors in a large cohort of adult outpatients. (2009) (0)
- No correlation between lipoprotein(a) and biochemical markers of renal function in the general population. (2008) (0)
- Letter: non‐alcoholic fatty liver disease is associated with a history of osteoporotic fractures but not with low bone mineral density—authors’ reply (2019) (0)
- NAFLD in the 20's. From Epidemiology to Management (PART - II). (2020) (0)
- Invited Review Old and new classes of glucose-lowering agents as treatments for non-alcoholic fatty liver disease: a narrative review (2022) (0)
- Controlling nutritional status score predicts 2-year outcomes in elderly patients admitted for acute heart failure. (2023) (0)
- N-terminal propeptide of type 3 collagen-based sequential algorithm can identify high-risk steatohepatitis and fibrosis in MAFLD (2022) (0)
- How should endocrinologists diagnose and treat non-alcoholic fatty liver disease? (2022) (0)
- Prostatic Cancer, Hypogonadism, and Insulin Resistance (2006) (0)
- C>G variant influences the association between 2 visceral fat and significant fibrosis in biopsy-proven NAFLD (2021) (0)
- LEARN algorithm: a novel option for predicting non-alcoholic steatohepatitis (2022) (0)
- Metformin in polycystic ovary syndrome. (2008) (0)
- Interaction of SAMM50-rs738491, PARVB-rs5764455 and PNPLA3-rs738409 Increases Susceptibility to Nonalcoholic Steatohepatitis (2021) (0)
- The gut microbiome and nicotine metabolism in NAFLD. (2023) (0)
- Novel urinary protein panels for the non-invasive diagnosis of nonalcoholic fatty liver disease and fibrosis stages. (2023) (0)
- Impact of genetic polymorphisms associated with NAFLD on hepatic and vascular complications in diabetes (2019) (0)
- Endothelial dysfunction and cardiovascular risk profile in patients with chronic hepatitis C virus infection (2013) (0)
- Running title: NAFLD, CVD and type 2 diabetes (2007) (0)
- Plasma factor VII levels: Relationships to fatty acid composition of adipose tissue in healthy men (1995) (0)
- Hepatocytic ballooning in non-alcoholic steatohepatitis: Dilemmas and future directions. (2023) (0)
- Migraine, valproic acid, and lipoprotein(a). (2009) (0)
- Subject Index Vol. 117, 2007 (2007) (0)
- IDDF2022-ABS-0120 Hepatocyte apoptosis fragment product cytokeratin-18 M30 and non-alcoholic steatohepatitis risk prediction: an international registry study (2022) (0)
- Carotid atherosclerosis and rheumatoid arthritis. Commentary and Authors' reply (2006) (0)
- Association between increased carotid intima-media thickness and higher serum C-terminal telopeptide of type 1 collagen levels in post-menopausal women with type 2 diabetes. (2020) (0)
- Insulin effect on serum potassium and auto‐inhibition of insulin secretion is intact in a patient with leprechaunism despite severe impairment of substrates metabolism (2008) (0)
- NAFLD: a multisystem disease requiring a multidisciplinary and holistic approach (2021) (0)
- 247 HEPATIC T1-TIME, CARDIAC STRUCTURE, FUNCTION AND CARDIOVASCULAR OTUCOMES IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION UNDERGOING CARDIAC MAGNETIC RESONANCE IMAGING (2022) (0)
- Causal relationships between genetically predicted circulating levels of amino acids and NAFLD risk: a Mendelian randomisation study (2023) (0)
- PNPLA3 rs738409 C>G Variant Influences the Association Between Visceral Fat and Significant Fibrosis in Biopsy-proven Nonalcoholic Fatty Liver Disease (2021) (0)
- Carotid Atherosclerosis and Rheumatoid Arthritis (2006) (0)
- Long-term outcomes in patients with non-alcoholic fatty liver disease: further evidence that a multidisciplinary and patient-centred approach to treatment is needed. (2021) (0)
- Comparative Associations of Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction–Associated Fatty Liver Disease With Coronary Artery Calcification: A Cross-Sectional and Longitudinal Cohort Study (2023) (0)
- The use of recombinant activated FVII in post-partum hemorrhage. [Review] (2010) (0)
- Investigation of synbiotic treatment in non-alcoholic fatty liver disease (INSYTE study): a double-blind, randomised, placebo-controlled, phase 2 trial (2020) (0)
- THU-323-Impact of genetic polymorphisms associated with NAFLD on hepatic and vascular complications in diabetes (2019) (0)
- Diffuse Idiopathic Skeletal Hyperostosis (DISH) in Type 2 Diabetes: A New Imaging Possibility and a New Biomarker (2020) (0)
- NAFLD, Diabetes, and Other Endocrine Diseases: Clinical Implications (2020) (0)
- Increased red blood cell distribution width and platelet‑to‑lymphocyte ratio for predicting all‑cause mortality in patients with type 2 diabetes and advanced heart failure: a causal association or epiphenomenon? (2019) (0)
- Nonalcoholic Fatty Liver Disease Is AssociatedWith Left Ventricular Diastolic Dysfunction in PatientsWith Type 2 Diabetes (2011) (0)
- P1737 Echocardiographic estimation of pulmonary artery pressure in young non-complicated patients with type 1 diabetes: results from a single-center observational study (2020) (0)
- Simultaneous Measurements of Urinary Free Cortisol and Cortisone for the Assessment of Functional (2007) (0)
- A Special Thanks to the Reviewers of Diabetes (2016) (0)
- The white blood cell count:its relatioship to plasma insulin and other cardiovascular risk factors in healthy male (1996) (0)
- Predictable impact of the routine implementation of the CKD-EPI equation for estimating glomerular filtration rate by a simulation study (2012) (0)
- Higher Levels of Plasma Hyaluronic Acid and N-terminal Propeptide of Type III Procollagen Are Associated With Lower Kidney Function in Children With Non-alcoholic Fatty Liver Disease (2022) (0)
- Risk of atrial fibrillation in patients with nonalcoholic steatohepatitis (2019) (0)
- The hepato-ovarian axis: genetic evidence for a causal association between non-alcoholic fatty liver disease and polycystic ovary syndrome (2023) (0)
- Hepatocyte apoptosis fragment product cytokeratin-18 M30 level and non-alcoholic steatohepatitis risk diagnosis: an international registry study (2023) (0)
- Vitamin D, parathyroid hormone levels and biochemical components of the metabolic syndrome in women. (2007) (0)
- Comparison between MAFLD and NAFLD definitions for identifying patients at higher risk of chronic kidney disease (2020) (0)
- Authors' reply to Zhang. (2022) (0)
- Nonalcoholic fatty liver disease and cardiovascular disease risk. [Review] (2010) (0)
- Reply to Dr. Chiang's comments. (2023) (0)
- The Prevalence of Cardiovascular AutonomicNeuropathy in a Cohort of Patients With Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes (2015) (0)
- Estimated peak systolic pulmonary artery pressure in young non-complicated patients with type 1 diabetes. (2020) (0)
- Contents Vol. 117, 2007 (2007) (0)
- Diagnostic accuracy of FibroScan-AST (FAST) score for the non-invasive identification of patients with fibrotic non-alcoholic steatohepatitis: a systematic review and meta-analysis. (2023) (0)
- NAFLD fibrosis score identifies not only advanced liver fibrosis but also chronic vascular complications in type 2 diabetic patients (2020) (0)
- A combined and sequential non-invasive approach to diagnosing non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease and persistently normal alanine aminotransferase levels (2020) (0)
- Potential Role of CB2 Receptors in Cannabis Smokers With Chronic Hepatitis C (2005) (0)
- Sex differences in cardiovascular disease and cardiovascular risk estimation in patients with type 1 diabetes. (2023) (0)
- 122 RELATIONSHIP OF SERUM GAMMA-GLUTAMYLTRANSFERASE WITH ATHEROGENIC DYSLIPIDEMIA AND GLYCEMIC CONTROL IN TYPE 2 DIABETES (2008) (0)
- RESPONSE: LETTER TO THE EDITOR (2008) (0)
- Association between KLF6 rs3750861 polymorphism and plasma ceramide concentrations in post-menopausal women with type 2 diabetes. (2022) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Giovanni Targher?
Giovanni Targher is affiliated with the following schools:
